Cargando…

Pharmacokinetics of Zidovudine Dosed Twice Daily According to World Health Organization Weight Bands in Ugandan HIV-infected Children

Data on zidovudine pharmacokinetics in children dosed using World Health Organization weight bands are limited. About 45 HIV-infected, Ugandan children, 3.4 (2.6–6.2) years, had intensive pharmacokinetic sampling. Geometric mean zidovudine AUC(0–12h) was 3.0 h.mg/L, which is higher than previously o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fillekes, Quirine, Kendall, Lindsay, Kitaka, Sabrina, Mugyenyi, Peter, Musoke, Philippa, Ndigendawani, Milly, Bwakura-Dangarembizi, Mutsa, Gibb, Diana M., Burger, David, Walker, Ann Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Williams & Wilkins 2014
Materias:	HIV Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990384/ https://www.ncbi.nlm.nih.gov/pubmed/24736440 http://dx.doi.org/10.1097/INF.0000000000000143

Ejemplares similares

Pharmacokinetics of lamivudine, abacavir and zidovudine administered twice daily as syrups versus scored tablets in HIV-1-infected Ugandan children
por: Gitta, PK, et al.
Publicado: (2010)

Prevalence of Lipodystrophy and Metabolic Abnormalities in HIV-infected African Children after 3 Years on First-line Antiretroviral Therapy
por: Bwakura-Dangarembizi, Mutsawashe, et al.
Publicado: (2015)

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy
por: Crook, Angela M., et al.
Publicado: (2016)

Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092
por: Owor, Maxensia, et al.
Publicado: (2021)

Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial
por: Siika, Abraham, et al.
Publicado: (2018)

Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis
por: Prendergast, Andrew J., et al.
Publicado: (2016)

Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort
por: Scarsi, Kimberly K., et al.
Publicado: (2016)

Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children
por: Parikh, Sunil, et al.
Publicado: (2016)

“I don't feel shy because I will be among others who are just like me…”: The role of support groups for children perinatally infected with HIV in Zimbabwe
por: Mupambireyi, Zivai, et al.
Publicado: (2014)

Mortality in the Year Following Antiretroviral Therapy Initiation in HIV-Infected Adults and Children in Uganda and Zimbabwe
por: Walker, A. Sarah, et al.
Publicado: (2012)

Effect of comprehensive knowledge of HIV on risky sexual behaviours associated with HIV transmission among adult Ugandans: a propensity score-matched analysis
por: Izudi, Jonathan, et al.
Publicado: (2022)

A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study)
por: Kumar, Princy N, et al.
Publicado: (2009)

Growth differences by school-age and adolescence according to in utero and peripartum antiretroviral therapy exposure among Ugandan children
por: Awadu, Jorem E., et al.
Publicado: (2023)

Ethical and legal constraints to children’s participation in research in Zimbabwe: experiences from the multicenter pediatric HIV ARROW trial
por: Bwakura-Dangarembizi, Mutsa, et al.
Publicado: (2012)

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial
por: Szubert, Alexander J., et al.
Publicado: (2017)

Opportunities for improving the efficiency of paediatric HIV treatment programmes
por: Revill, Paul A., et al.
Publicado: (2015)

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
por: Turkova, Anna, et al.
Publicado: (2022)

Child Growth According to Maternal and Child HIV Status in Zimbabwe
por: Omoni, Adetayo O., et al.
Publicado: (2017)

Zidovudine.
por: Sperling, R
Publicado: (1998)

Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy
por: Prendergast, Andrew J., et al.
Publicado: (2016)

Micronutrients and nutritional status among children living with HIV with and without severe acute malnutrition: IMPAACT P1092
por: Bwakura-Dangarembizi, Mutsa, et al.
Publicado: (2023)

Marginal structural models for repeated measures where intercept and slope are correlated: An application exploring the benefit of nutritional supplements on weight gain in HIV-infected children initiating antiretroviral therapy
por: Farmer, Ruth E., et al.
Publicado: (2020)

Effect of handrubbing using locally-manufactured alcohol-based handrubs in paediatric wards in Harare, Zimbabwe
por: Gudza-Mugabe, Muchaneta, et al.
Publicado: (2017)

Carriage of antibiotic-resistant Enterobacteriaceae in hospitalised children in tertiary hospitals in Harare, Zimbabwe
por: Magwenzi, Marcelyn T., et al.
Publicado: (2017)

Differences in Growth of HIV-exposed Uninfected Infants in Ethiopia According to Timing of In-utero Antiretroviral Therapy Exposure
por: Ejigu, Yohannes, et al.
Publicado: (2020)

Postdischarge interventions for children hospitalized with severe acute malnutrition: a systematic review and meta-analysis
por: Noble, Christie C A, et al.
Publicado: (2021)

Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 Trial
por: Bevers, Lisanne A H, et al.
Publicado: (2023)

Metabolic complications and treatment of perinatally HIV-infected children and adolescents
por: Barlow-Mosha, Linda, et al.
Publicado: (2013)

HIV self-test performance among female sex workers in Kampala, Uganda: a cross-sectional study
por: Ortblad, Katrina F, et al.
Publicado: (2018)

Qualitative study of the BREATHER trial (Short Cycle antiretroviral therapy): is it acceptable to young people living with HIV?
por: Bernays, Sarah, et al.
Publicado: (2017)

Zidovudine-induced myopathy
por: Wiwanitkit, Viroj
Publicado: (2011)

Zidovudine Induced Hyperpigmentation
por: Premjith, Raveendran, et al.
Publicado: (2022)

Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study
por: Aboud, M, et al.
Publicado: (2010)

Suboptimal patterns of provider initiated HIV testing and counselling, antiretroviral therapy eligibility assessment and referral in primary health clinic attendees in Blantyre, Malawi*
por: MacPherson, Peter, et al.
Publicado: (2012)

THE INFLUENCE OF HIV-1 SUBTYPES C, CRF31_BC AND B ON DISEASE PROGRESSION AND INITIAL VIROLOGIC RESPONSE TO HAART IN A SOUTHERN BRAZILIAN COHORT
por: Nunes, Cynara Carvalho, et al.
Publicado: (2014)

DETERMINATION OF VIRAL TROPISM BY GENOTYPING AND PHENOTYPING ASSAYS IN BRAZILIAN HIV-1-INFECTED PATIENTS
por: Arruda, Liã Bárbara, et al.
Publicado: (2014)

Description of the cascade of care and factors associated with attrition before and after initiating antiretroviral therapy of HIV infected children in a cohort study in India
por: Alvarez-Uria, Gerardo
Publicado: (2014)

DISCORDANCE BETWEEN BODY MASS INDEX AND ANTHROPOMETRIC MEASUREMENTS AMONG HIV-1-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY AND WITH LIPOATROPHY/LIPOHYPERTROPHY SYNDROME
por: SOARES, Lismeia Raimundo, et al.
Publicado: (2015)

PRETERM BIRTH AND FETAL GROWTH RESTRICTION IN HIV-INFECTED BRAZILIAN PREGNANT WOMEN
por: dos REIS, Helena Lucia Barroso, et al.
Publicado: (2015)

A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation Model
por: Nakagawa, Fumiyo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_71iu8ftacon3vij4ec2sgst6o8